SCREENING FEE. Daiichi shall pay to Anadys a nonrefundable-screening fee of Four Hundred Thousand United States Dollars (US $400,000) within twenty-one (21) days after the Effective Date.
Appears in 1 contract
Sources: Confidentiality Agreement (Anadys Pharmaceuticals Inc)
SCREENING FEE. Daiichi shall pay to Anadys a nonrefundable-screening fee of Four Hundred Thousand [...***...] United States Dollars (US $400,000[...***...]) within twenty-one (21) days after the Effective Date.
Appears in 1 contract
Sources: Confidentiality Agreement (Anadys Pharmaceuticals Inc)